Skip to main content

JPMORGAN CHASE & CO

Position in AVTX — Avalo Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in AVTX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$335,319
-$2,566,938 QoQ
Shares Held
18,145
-90.7% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 126 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 5% Shared 0% None 95%

Common Shares in AVTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. AVTX ranks #212 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVTX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $335,319 18,145
2026-03-31 $2,902,257 194,391
2025-12-31 $806,866 44,431
2025-09-30 $19,992 1,573
2025-06-30 $368 74
2025-03-31 $8,851 1,105
2024-12-31 $14 2
2024-09-30 $19 2
2024-06-30 $24 2
2024-03-31 $43 2
2023-12-31 $18 2
2023-06-30 $4,612 12,993
2023-03-31 $176 101
2022-06-30 $923 1,848
2022-03-31 $21,193 29,233
2021-12-31 $82,481 48,519
2021-09-30 $44,473 20,401
2021-06-30 CERC 59,725
2021-03-31 CERC 116,544
2020-12-31 CERC 97,004
2020-09-30 CERC 25,113
2020-06-30 CERC 25,376
2020-03-31 CERC 45,569